


Ask a doctor about a prescription for LOSARTAN/HYDROCHLOROTHIAZIDE KRKA 50 mg/12.5 mg FILM-COATED TABLETS
Package Leaflet: Information for the Patient
Losartan/Hydrochlorothiazide Krka 50 mg/12.5 mg Film-Coated Tablets EFG
losartan potassium/hydrochlorothiazide
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
Losartan/Hydrochlorothiazide Krka is a combination of an angiotensin II receptor antagonist (losartan) and a diuretic (hydrochlorothiazide). Angiotensin II is a substance produced in the body which binds to receptors in blood vessels, causing them to narrow. This leads to an increase in blood pressure. Losartan prevents the binding of angiotensin II to these receptors, resulting in the blood vessels relaxing, which in turn lowers the blood pressure. Hydrochlorothiazide works by making the kidneys remove more water and salts. This also helps to reduce blood pressure.
Losartan/Hydrochlorothiazide Krka is indicated for the treatment of essential hypertension (high blood pressure).
Do not takeLosartan/Hydrochlorothiazide Krka
Warnings and precautions
Consult your doctor or pharmacist before starting treatment with Losartan/Hydrochlorothiazide Krka.
It is important that you inform your doctor before taking Losartan/Hydrochlorothiazide Krka:
Your doctor may check your kidney function, blood pressure and blood electrolyte levels (e.g. potassium) at regular intervals.
See also the information under the heading “Do not take Losartan/Hydrochlorothiazide Krka”.
Consult your doctor if you experience abdominal pain, nausea, vomiting or diarrhoea after taking Losartan/Hydrochlorothiazide Krka. Your doctor will decide whether to continue treatment. Do not stop taking Losartan/Hydrochlorothiazide Krka on your own.
You should inform your doctor if you think you are pregnant (or might be). It is not recommended to take Losartan/Hydrochlorothiazide Krka at the start of pregnancy and it should not be taken if you are more than 3 months pregnant as it may cause serious harm to your baby if used during this period (see section pregnancy).
Other medicines and Losartan/Hydrochlorothiazide Krka
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
Tell your doctor if you are taking potassium supplements, salt substitutes that contain potassium, potassium-sparing medicines or other medicines that may increase potassium levels in the blood (e.g. trimethoprim-containing medicines), as this combination is not recommended with Losartan/Hydrochlorothiazide Krka.
Diuretics such as hydrochlorothiazide contained in Losartan/Hydrochlorothiazide Krka may interact with other medicines. Preparations containing lithium should not be taken with Losartan/Hydrochlorothiazide Krka without your doctor carrying out close monitoring. Special precautions may be necessary (e.g. blood tests) if you are taking diuretics (water tablets), certain laxatives, gout treatments, heart rate control medicines or diabetes medicines (oral or insulin).
It is also important that your doctor knows if you are taking:
Your doctor may need to change your dose and/or take other precautions:
Please, when taking Losartan/Hydrochlorothiazide Krka, inform your doctor if you are going to have a radiographic test with an iodine-containing contrast medium.
TakingLosartan/Hydrochlorothiazide Krkawith food, drinks and alcohol
It is recommended that you do not drink alcohol while taking these tablets: alcohol and Losartan/Hydrochlorothiazide Krka tablets may increase the effects of each other.
Excessive salt in the diet may counteract the effect of losartan and hydrochlorothiazide tablets.
Losartan/Hydrochlorothiazide Krka tablets can be taken with or without food.
Grapefruit juice should be avoided while taking losartan/hydrochlorothiazide.
Pregnancy and breast-feeding
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Pregnancy
You should inform your doctor if you think you are pregnant (or might be). Your doctor will normally advise you to stop taking Losartan/Hydrochlorothiazide Krka before you become pregnant or as soon as you know you are pregnant and will recommend that you take another medicine instead of losartan/hydrochlorothiazide. Losartan/Hydrochlorothiazide Krka is not recommended during pregnancy, and should not be taken if you are more than 3 months pregnant, as it may cause serious harm to your baby if used after the third month of pregnancy.
Breast-feeding
Tell your doctor if you are breast-feeding or about to start breast-feeding. It is not recommended to take Losartan/Hydrochlorothiazide Krka if you are breast-feeding, and your doctor may choose another treatment for you if you want to continue breast-feeding.
Children and adolescents
There is no experience with the use of Losartan/Hydrochlorothiazide Krka in children. Therefore, Losartan/Hydrochlorothiazide Krka should not be given to children.
Use in elderly patients
Losartan/Hydrochlorothiazide Krka works in the same way and is equally well tolerated by most elderly and young patients. Most elderly patients require the same dose as younger patients.
Driving and using machines
When you start treatment with this medicine, you should not perform tasks that require special attention (e.g. driving a car or using hazardous machinery) until you know how your medicine affects you.
Losartan/Hydrochlorothiazide Krkacontains lactose
If your doctor has told you that you have an intolerance to some sugars, contact them before taking this medicine.
Use in athletes: this medicine contains hydrochlorothiazide which may produce a positive result in doping tests.
Follow exactly the administration instructions of this medicine given by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
Your doctor will decide the appropriate dose of losartan/hydrochlorothiazide depending on your condition and whether you are taking other medicines. It is important to keep taking this medicine while your doctor prescribes it to maintain constant blood pressure control.
High blood pressure
For most patients with high blood pressure, the usual dose is 1 tablet of Losartan/Hydrochlorothiazide Krka 50 mg/12.5 mg per day to control blood pressure over 24 hours. This can be increased to 2 tablets of Losartan/Hydrochlorothiazide Krka 50 mg/12.5 mg per day or changed to 1 tablet of Losartan/Hydrochlorothiazide 100 mg/25 mg (a stronger dose) per day. The maximum daily dose is 2 tablets of Losartan/Hydrochlorothiazide Krka 50 mg/12.5 mg per day or 1 tablet of Losartan/Hydrochlorothiazide 100 mg/25 mg per day.
Administration
The tablets should be swallowed with a glass of water.
If you take more Losartan/Hydrochlorothiazide Krka than you should
In case of overdose, contact your doctor immediately or go directly to the hospital for immediate medical attention. Overdose may cause a drop in blood pressure, palpitations, slow pulse, changes in blood composition and dehydration.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, telephone: 91 562 04 20, indicating the medicine and the amount taken.
If you forget to take Losartan/Hydrochlorothiazide Krka
Do not take a double dose to make up for forgotten doses.
Try to take this medicine at the same time each day as prescribed by your doctor. However, if you miss a dose, do not take an extra dose. Simply return to your regular schedule.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.
If you experience the following, stop taking Losartan/Hydrochlorothiazide Krka 50 mg/12.5 mg tablets and inform your doctor immediately or go to the emergency department of your nearest hospital:
A severe allergic reaction (skin rash, itching, swelling of the face, lips, mouth, or throat that can cause difficulty swallowing or breathing).
This is a serious but rare side effect that may affect more than 1 person in 10,000, but less than 1 patient in 1,000. It may require urgent medical attention or hospitalization.
The following adverse effects have been reported:
Frequent (may affect up to 1 in 10 people):
Infrequent (may affect up to 1 in 100 people):
Rare (may affect up to 1 in 1,000 people):
Very rare (may affect up to 1 in 10,000 people):
Frequency not known (cannot be estimated from the available data):
If you consider that any of the adverse effects you are experiencing is serious or if you notice any adverse effect not mentioned in this leaflet, inform your doctor or pharmacist.
Reporting of Adverse Effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that does not appear in this leaflet. You can also report them directly through the national reporting system: Spanish Pharmacovigilance System for Human Use Medicines: www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
Do not store above 30°C. Store in the original packaging to protect it from moisture.
Medicines should not be disposed of through wastewater or household waste. Deposit the packaging and medicines you no longer need at the SIGRE collection point in the pharmacy. Ask your pharmacist how to dispose of the packaging and medicines you no longer need. This way, you will help protect the environment.
Composition of Losartan/Hydrochlorothiazide Krka 50 mg/12.5 mg
Each film-coated tablet contains 50 mg of losartan potassium (equivalent to 45.76 mg of losartan) and 12.5 mg of hydrochlorothiazide.
Appearance of the Product and Package Contents
The film-coated tablets are yellow, oval, moderately biconvex with a score line on one side, and have dimensions of 6 mm x 12 mm (oval shape) and a thickness of 3.8 - 4.7 mm.
The score line is only for breaking and facilitating swallowing, but not for dividing into equal doses.
Package size:28 film-coated tablets in a PVC/PVDC//Al blister pack and carton.
Marketing Authorization Holder and Manufacturer
KRKA, d.d., Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Slovenia
You can request more information about this medicine by contacting the local representative of the marketing authorization holder:
KRKA Farmacéutica, S.L., C/ Anabel Segura 10, Pta. Baja, Oficina 1, 28108 Alcobendas, Madrid, Spain
This medicine is authorized in the member states of the European Economic Area and in the United Kingdom (Northern Ireland) with the following names:
Member State | Medicine Name |
Austria | Losartan/HCT Krka |
Czech Republic | Lorista H |
Cyprus | Losartan/Hydrochlorothiazide Krka |
Germany | Losartan-Kalium HCTad |
Denmark | Losartankalium/hydrochlorthiazid Krka |
Estonia | Lorista H |
Spain | Losartan/Hidroclorotiazida Krka |
Finland | Losartan/Hydrochlorothiazide Krka |
Hungary | Lavestra H |
Iceland | Losartankalium/hydrochlorthiazid Krka |
Italy | Losartan e Idroclorotiazide Krka |
Lithuania | Lorista H |
Latvia | Lorista H |
Norway | Losartan/Hydrochlorothiazide Krka |
Poland | Lorista HD |
Portugal | Losartan + Hidroclorotiazida Krka |
Romania | Lorista HD |
Sweden | Losartan/Hydrochlorothiazide Krka |
Slovakia | Lorista H |
United Kingdom (Northern Ireland) | Losartan Potassium/Hydrochlorothiazide |
Date of the last revision of this leaflet:June 2025
Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
The average price of LOSARTAN/HYDROCHLOROTHIAZIDE KRKA 50 mg/12.5 mg FILM-COATED TABLETS in November, 2025 is around 2.92 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for LOSARTAN/HYDROCHLOROTHIAZIDE KRKA 50 mg/12.5 mg FILM-COATED TABLETS – subject to medical assessment and local rules.